The RNA-dependent RNA polymerase of the influenza A virus

Future Virology

Volumn 9, Issue 9, 2014, Pages 863-876

  Stubbs, Thomas M ^a,b   Te Velthuis, Aartjan J W ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

adaptation; host restriction; influenza A; replication; RNA polymerase; structure; transcription

Indexed keywords

POLYMERASE BASIC PROTEIN 1; POLYMERASE BASIC PROTEIN 2; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG;

CELL NUCLEUS; ENZYME STRUCTURE; HOST; INFLUENZA VIRUS A; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA BINDING; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 84908230625     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.14.66     Document Type: Review

References (97)

1. Taubenberger JK, Morens DM. Pandemic infuenza-including a risk assessment of H5N1. Rev. Sci. Tech. 28(1), 187-202 (2009).
2. Presti RM, Zhao G, Beatty WL et al. Quaranfl, Johnston Atoll, and Lake Chad viruses are novel members of the family Orthomyxoviridae. J. Virol. 83(22), 11599-11606 (2009).
3. Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) infuenza virus pandemic: a review. Vaccine 28 (31), 4895-4902 (2010).
4. Das K. Antivirals targeting infuenza A virus. J. Med. Chem. 55(14), 6263-6277 (2012).
5. Ekiert DC, Wilson IA. Broadly neutralizing antibodies against infuenza virus and prospects for universal therapies. Curr. Opin. Virol. 2(2), 134-141 (2012).
6. Krammer F, Palese P. Universal infuenza virus vaccines: need for clinical trials. Nat. Immunol. 15(1), 3-5 (2014).
7. Herfst S, Schrauwen EJ, Linster M et al. Airborne transmission of infuenza A/H5N1 virus between ferrets. Science 336(6088), 1534-1541 (2012).
8. Qi L, Davis AS, Jagger BW et al. Analysis by single-gene reassortment demonstrates that the 1918 infuenza virus is functionally compatible with a low-pathogenicity avian infuenza virus in mice. J. Virol. 86 (17), 9211-9220 (2012).
9. Dubois J, Terrier O, Rosa-Calatrava M. Infuenza viruses and mRNA splicing: doing more with less. MBio 5(3), e00070-14 (2014).
10. Robertson JS. 5 and 3 terminal nucleotide sequences of the RNA genome segments of infuenza virus. Nucleic Acids Res. 6(12), 3745-3758 (1979).
11. Fodor E, Pritlove DC, Brownlee GG. The infuenza virus panhandle is involved in the initiation of transcription. J. Virol. 68(6), 4092-4096 (1994).
12. Baudin F, Bach C, Cusack S, Ruigrok RW. Structure of infuenza virus RNP. I. Infuenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J. 13 (13), 3158-3165 (1994).
13. Arranz R, Coloma R, Chichón FJ et al. The structure of native infuenza virion ribonucleoproteins. Science 338 (6114), 1634-1637 (2012).
14. Jackson DA, Caton AJ, McCready SJ, Cook PR. Infuenza virus RNA is synthesized at fxed sites in the nucleus. Nature 296(5855), 366-368 (1982).
15. Engelhardt OG, Smith M, Fodor E. Association of the infuenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J. Virol. 79(9), 5812-5818 (2005).
16. Krug RM, Broni BA, Bouloy M. Are the 5 ends of infuenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell 18(2), 329-334 (1979).
17. Geerts-Dimitriadou C, Goldbach R, Kormelink R. Preferential use of RNA leader sequences during infuenza A transcription initiation in vivo. Virology 409(1), 27-32 (2011).
18. Poon LL, Pritlove DC, Fodor E, Brownlee GG. Direct evidence that the poly (A) tail of infuenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J. Virol. 73(4), 3473-3476 (1999).
19. York A, Hengrung N, Vreede FT, Huiskonen JT, Fodor E. Isolation and characterization of the positive-sense replicative intermediate of a negative-strand RNA virus. Proc. Natl. Acad. Sci. USA 110 (45), E4238-E4245 (2013).
20. Vreede FT, Brownlee GG. Infuenza virion-derived viral ribonucleoproteins synthesize both mRNA and cRNA in vitro. J. Virol. 81, 2196-2204 (2007).
21. Lee MT, Bishop K, Medcalf L, Elton D, Digard P, Tiley L. Defnition of the minimal viral components required for the initiation of unprimed RNA synthesis by infuenza virus RNA polymerase. Nucleic Acid. Res. 30, 429-438 (2002).
22. Resa-Infante P, Recuero-Checa MA, Zamarreño N, Llorca O, Ortín J. Structural and functional characterization of an infuenza virus RNA polymerase-genomic RNA complex. J. Virol. 84(20), 10477-10487 (2010).
23. Turrell L, Lyall JW, Tiley LS, Fodor E, Vreede FT. The role and assembly mechanism of nucleoprotein in infuenza A virus ribonucleoprotein complexes. Nat. Commun. 4, 1591 (2013).
24. Bruenn JA. A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. Nucleic Acids Res. 31(7), 1821-1829 (2003).
25. Chu C, Fan S, Li C et al. Functional analysis of conserved motifs in infuenza virus PB1 protein. PLoS ONE 7, e36113 (2012).
26. Biswas SK, Nayak DP. Mutational analysis of the conserved motifs of infuenza A virus polymerase basic protein 1. J. Virol. 68(3), 1819-1826 (1994).
27. Deng T, Sharps J, Fodor E, Brownlee GG. In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of infuenza A virus polymerase subunits into a functional trimeric complex. J. Virol. 79(13), 8669-8674 (2005).
28. Fodor E, Smith M. The PA subunit is required for effcient nuclear accumulation of the PB1 subunit of the infuenza A virus RNA polymerase complex. J. Virol. 78 (17), 9144-9153 (2004).
29. Obayashi E, Yoshida H, Kawai F et al. The structural basis for an essential subunit interaction in infuenza virus RNA polymerase. Nature 454 (7208), 1127-1131 (2008).
30. Sugiyama K, Obayashi E, Kawaguchi A et al. Structural insight into the essential PB1-PB2 subunit contact of the infuenza virus RNA polymerase. EMBO J. 28(12), 1803-1811 (2009).
31. Mänz B, Götz V, Wunderlich K et al. Disruption of the viral polymerase complex assembly as a novel approach to attenuate infuenza A virus. J. Biol. Chem. 286 (10), 8414-8424 (2011).
32. Muratore G, Goracci L, Mercorelli B et al. Small molecule inhibitors of infuenza A and B viruses that act by disrupting subunit interactions of the viral polymerase. Proc. Natl. Acad. Sci. USA 109(16), 6247-6252 (2012).
33. Tarendeau F, Crepin T, Guilligay D, Ruigrok RW, Cusack S, Hart DJ. Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of infuenza virus polymerase PB2 subunit. PLoS Pathog. 4(8), e1000136 (2008).
34. Boivin S, Hart DJ. Interaction of the infuenza A virus polymerase PB2 C-terminal region with importin alpha isoforms provides insights into host adaptation and polymerase a s sembly. J. Biol. Chem. 286(12), 10439-10448 (2011).
35. Guilligay D, Tarendeau F, Resa-Infante P et al. The structural basis for cap binding by infuenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 15(5), 500-506 (2008).
36. Pautus S, Sehr P, Lewis J et al. New 7-methylguanine derivatives targeting the infuenza polymerase PB2 cap-binding domain. J. Med. Chem. 56(21), 8915-8930 (2013).
37. Guu TS, Dong L, Wittung-Stafshede P, Tao YJ. Mapping the domain structure of the infuenza A virus polymerase acidic protein (PA) and its interaction with the basic protein 1 (PB1) subunit. Virology 379(1), 135-142 (2008).
38. Fodor E, Crow M, Mingay LJ et al. A single amino acid mutation in the PA subunit of the infuenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J. Virol. 76(18), 8989-9001 (2002).
39. Moeller A, Kirchdoerfer RN, Potter CS, Carragher B, Wilson IA. Organization of the infuenza virus replication machinery. Science 338, 1631-1634 (2012).
40. Dias A, Bouvier D, Crépin T et al. The cap-snatching endonuclease of infuenza virus polymerase resides in the PA subunit. Nature 458 (7240), 914-918 (2009).
41. Yuan P, Bartlam M, Lou Z et al. Crystal structure of an avian infuenza polymerase PA(N) reveals an endonuclease active site. Nature 458(7240), 909-913 (2009).
42. Datta K, Wolkerstorfer A, Szolar OH, Cusack S, Klumpp K. Characterization of PA-N terminal domain of Infuenza A polymerase reveals sequence specifc RNA cleavage. Nucleic Acids Res. 41(17), 8289-8299 (2013).
43. Kowalinski E, Zubieta C, Wolkerstorfer A, Szolar OH, Ruigrok RW, Cusack S. Structural analysis of specifc metal chelating inhibitor binding to the endonuclease domain of infuenza pH1N1 (2009) polymerase. PLoS Pathog. 8(8), e1002831 (2012).
44. Gabriel G, Herwig A, Klenk HD. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of infuenza A virus. PLoS Pathog. 4(2), e11 (2008).
45. Resa-Infante P, Jorba N, Zamarreño N, Fernández Y, Juárez S, Ortín J. The host-dependent interaction of alpha-importins with infuenza PB2 polymerase subunit is required for virus RNA replication. PLoS ONE 3(12), e3904 (2008).
46. Huet S, Avilov SV, Ferbitz L, Daigle N, Cusack S, Ellenberg J. Nuclear import and assembly of infuenza A virus RNA polymerase studied in live cells by fuorescence cross-correlation spectroscopy. J. Virol. 84(3), 1254-1264 (2010).
47. Hemerka JN, Wang D, Weng Y et al. Detection and characterization of infuenza A virus PA-PB2 interaction through a bimolecular fuorescence complementation a ssay. J. Virol. 83(8), 3944-3955 (2009).
48. Coloma R, Valpuesta JM, Arranz R, Carrascosa JL, Ortín J, Martín-Benito J. The structure of a biologically active infuenza virus ribonucleoprotein complex. PLoS Pathog. 5(6), e1000491 (2009).
49. Torreira E, Schoehn G, Fernández Y et al. Three-dimensional model for the isolated recombinant infuenza virus polymerase heterotrimer. Nucleic Acids Res. 35(11), 3774-3783 (2007).
50. Area E, Martín-Benito J, Gastaminza P et al. 3D structure of the infuenza virus polymerase complex: localization of subunit domains. Proc. Natl Acad. Sci. USA 101(1), 308-313 (2004).
51. He X, Zhou J, Bartlam M et al. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian infuenza H5N1 virus. Nature 454(7208), 1123-1126 (2008).
52. Brownlee GG, Sharps JL. The RNA polymerase of infuenza a virus is stabilized by interaction with its viral RNA promoter. J. Virol. 76(14), 7103-7113 (2002).
53. Jung TE, Brownlee GG. A new promoter-binding site in the PB1 subunit of the infuenza A virus polymerase. J. Gen. Virol. 87(Pt3), 679-688 (2006).
54. Maier HJ, Kashiwagi T, Hara K, Brownlee GG. Differential role of the infuenza A virus polymerase PA subunit for vRNA and cRNA promoter binding. Virology 370(1), 194-204 (2008).
55. Vreede FT, Jung TE, Brownlee GG. Model suggesting that replication of infuenza virus is regulated by stabilization of replicative intermediates. J. Virol. 78(17), 9568-9572 (2004).
56. Vreede FT, Gifford H, Brownlee GG. Role of initiating nucleoside triphosphate concentrations in the regulation of infuenza virus replication and transcription. J. Virol. 82(14), 6902-6910 (2008).
57. Perez JT, Varble A, Sachidanandam R et al. Infuenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl Acad. Sci. USA 107(25), 11525-11530 (2010).
58. te Velthuis AJ, Turrell L, Vreede FT, Fodor E. Uncoupling of infuenza A virus transcription and replication through mutation of the unpaired adenosine in the viral RNA promoter. J. Virol. 87(18), 10381-10384 (2013).
59. Paterson D, te Velthuis AJ, Vreede FT, Fodor E. Host restriction of infuenza virus polymerase activity by PB2 627E is diminished on short viral templates in a nucleoprotein-independent manner. J. Virol. 88(1), 339-344 (2014).
60. Ng AK, Wang JH, Shaw PC. Structure and sequence analysis of infuenza A virus nucleoprotein. Sci. China C Life Sci. 52(5), 439-449 (2009).
61. Marklund JK, Ye Q, Dong J, Tao YJ, Krug RM. Sequence in the infuenza A virus nucleoprotein required for viral polymerase binding and RNA synthesis. J. Virol. 86, 7292-7297 (2012).
62. Moncorgé O, Mura M, Barclay WS. Evidence for avian and human host cell factors that affect the activity of infuenza virus polymerase. J. Virol. 84(19), 9978-9986 (2010).
63. Mehle A, Doudna JA. An inhibitory activity in human cells restricts the function of an avian-like infuenza virus polymerase. Cell Host Microbe 4(2), 111-122 (2008).
64. Imai M, Watanabe T, Hatta M et al. Experimental adaptation of an infuenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403), 420-428 (2012).
65. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 infuenza virus polymerase genes. Nature 437(7060), 889-893 (2005).
66. Gabriel G, Abram M, Keiner B, Wagner R, Klenk HD, Stech J. Differential polymerase activity in avian and mammalian cells determines host range of infuenza virus. J. Virol. 81(17), 9601-9604 (2007).
67. Subbarao EK, London W, Murphy BR. A single amino acid in the PB2 gene of infuenza A virus is a determinant of host range. J. Virol. 67(4), 1761-1764 (1993).
68. Bogs J, Kalthoff D, Veits J et al. Reversion of PB2-627E to-627K during replication of an H5N1 clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein. J. Virol. 85(20), 10691-10698 (2011).
69. Long JS, Howard WA, Núñez A et al. The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian infuenza virus is dependent on the virus lineage. J. Virol. 87(18), 9983-9996 (2013).
70. Mok CK, Lee HH, Lestra M et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 infuenza virus in mammalian hosts. J. Virol. 88(6), 3568-3576 (2014).
71. Foeglein Á, Loucaides EM, Mura M, Wise HM, Barclay WS, Digard P. Infuence of PB2 host-range determinants on the intranuclear mobility of the infuenza A virus polymerase. J. Gen. Virol. 92(Pt 7), 1650-1661 (2011).
72. Scull MA, Gillim-Ross L, Santos C et al. Avian infuenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathog. 5(5), e1000424 (2009).
73. Aggarwal S, Dewhurst S, Takimoto T, Kim B. Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of infuenza A virus polymerase complex. J. Biol. Chem. 286(40), 34504-34513 (2011).
74. Bortz E, Westera L, Maamary J et al. Host-and strain-specifc regulation of infuenza virus polymerase activity by interacting cellular proteins. MBio 2(4), e00151-11 (2011).
75. Cauldwell AV, Moncorgé O, Barclay WS. Unstable polymerase-nucleoprotein interaction is not responsible for avian infuenza virus polymerase restriction in human cells. J. Virol. 87(2), 1278-1284 (2013).
76. Herfst S, Chutinimitkul S, Ye J et al. Introduction of virulence markers in PB2 of pandemic swine-origin infuenza virus does not result in enhanced virulence or transmission. J. Virol. 84(8), 3752-3758 (2010).
77. Steel J, Lowen AC, Mubareka S, Palese P. Transmission of infuenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5(1), e1000252 (2009).
78. Zhou B, Pearce MB, Li Y et al. Asparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 infuenza A virus. PLoS ONE 8(6), e67616 (2013).
79. Hudjetz B, Gabriel G. Human-like PB2 627K infuenza virus polymerase activity is regulated by importin-α1 and-α7. PLoS Pathog. 8(1), e1002488 (2012).
80. Yamada S, Hatta M, Staker BL et al. Biological and structural characterization of a host-adapting amino acid in infuenza virus. PLoS Pathog. 6(8), e1001034 (2010).
81. Liu Q, Qiao C, Marjuki H et al. Combination of PB2 271A and SR polymorphism at positions 590/591 is critical for viral replication and virulence of swine infuenza virus in cultured cells and in vivo. J. Virol. 86(2), 1233-1237 (2012).
82. Bussey KA, Desmet EA, Mattiacio JL et al. PA residues in the 2009 H1N1 pandemic infuenza virus enhance avian infuenza virus polymerase activity in mammalian cells. J. Virol. 85(14), 7020-7028 (2011).
83. Song M-S, Pascua PNQ, Lee JH et al. The polymerase acidic protein gene of infuenza a virus contributes to pathogenicity in a mouse model. J. Virol. 83(23), 12325-12335 (2009).
84. Mehle A, Dugan VG, Taubenberger JK, Doudna JA. Reassortment and mutation of the avian infuenza virus polymerase PA subunit overcome species barriers. J. Virol. 86 (3), 1750-1757 (2012).
85. Zhu W, Zhu Y, Qin K et al. Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 infuenza virus in mice. PLoS ONE 7(3), e33383 (2012).
86. Hulse-Post DJ, Franks J, Boyd K et al. Molecular changes in the polymerase genes (PA and PB1) associated with high pathogenicity of H5N1 infuenza virus in mallard ducks. J. Virol. 81(16), 8515-8524 (2007).
87. Wise HM, Foeglein A, Sun J et al. A complicated message: Identifcation of a novel PB1-related protein translated from infuenza A virus segment 2 mRNA. J. Virol. 83(16), 8021-8031 (2009).
88. Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y. Identifcation of novel infuenza A virus proteins translated from PA mRNA. J. Virol. 87(5), 2455-2462 (2013).
89. Jagger BW, Wise HM, Kash JC et al. An overlapping protein-coding region in infuenza A virus segment 3 modulates the host response. Science 337(6091), 199-204 (2012).
90. Shi M, Jagger BW, Wise HM, Digard P, Holmes EC, Taubenberger JK. Evolutionary conservation of the PA-X open reading frame in segment 3 of infuenza A virus. J. Virol. 86(22), 12411-12413 (2012).
91. Tauber S, Ligertwood Y, Quigg-Nicol M, Dutia BM, Elliott RM. Behaviour of infuenza A viruses differentially expressing segment 2 gene products in vitro and in vivo. J. Gen. Virol. 93(Pt 4), 840-849 (2012).
92. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 infuenza A viruses contributes to increased virulence. PLoS Pathog. 3 (10), 1414-1421 (2007).
93. Gao S, von der Malsburg A, Dick A et al. Structure of myxovirus resistance protein a reveals intra-and intermolecular domain interactions required for the antiviral function. Immunity 35(4), 514-525 (2011).
94. Zimmermann P, Mänz B, Haller O, Schwemmle M, Kochs G. The viral nucleoprotein determines Mx sensitivity of infuenza A viruses. J. Virol. 85 (16), 8133-8140 (2011).
95. Mänz B, Dornfeld D, Götz V et al. Pandemic infuenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog. 9(3), e1003279 (2013).
96. Chow NL, Simpson RW. RNA-dependent RNA polymerase activity associated with virions and subviral particles of myxoviruses. Proc. Natl Acad. Sci. USA 68(4), 752-756 (1971).
97. Matrosovich MN, Gambaryan AS, Teneberg S et al. Avian infuenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptorbinding site. Virology 233(1), 224-234 (1997).